Development of a New Validated Stability Indicating RP-HPLC Method for the Determination of Irbesartan and Hydrochlorothiazide

Main Article Content

Topalli Srinivasu

Abstract

Introduction: Irbesartan (IRB) is an angiotensin receptor blocker used mainly for the treatment of hypertension. Hydrochlorothiazide (HCTZ) is a first-line diuretic drug of thiazide class which acts by lowering the blood pressure initially by increasing sodium and water excretion. A simple, precise, accurate, and robust stability-indicating liquid chromatographic method (gradient mode) was developed and validated for the simultaneous determination of IRB and HCTZ in pharmaceutical dosage forms (Tablets). Materials and Methods: Chromatographic separation was achieved on an X Bridge shield RP C-18 (150 mm × 3.0 mm, 3.5 μm) column of Waters high-performance liquid chromatography with Empower2 software and photodiode array detector, maintained at 45°C using 0.1% v/v formic acid:acetonitrile (40:60, v/v), with flow rate 0.8 ml/min (ultraviolet detection at 235 nm). Results and Discussion: HCTZ and IRB obey Beer–Lambert’s law over the concentration range of 2–600 μg/ml and 1.2–560 μg/ml, respectively, with regression equations y = 10669x −2468 (HCTZ) (R2 = 0.9999) and y = 18222x + 18180 (IRB) (R2 = 0.9997). The limit of quantification (LOQ) and limit of detection (LOD) for IRB were found to be 1.056 μg/ml and 0.349 μg/ml, respectively, whereas the LOQ and LOD for HCTZ were found to be 1.980 μg/ml and 0.654 μg/ml, respectively. IRB and HCTZ were subjected to stress conditions of acidic, alkaline, and oxidation degradations. The forced degradation studies were performed using HCl, NaOH, and H2O2. Conclusions: HCTZ and IRB are slightly sensitive toward alkaline conditions in comparison to other degradations. The method was validated as per ICH guidelines.

Downloads

Download data is not yet available.

Article Details

How to Cite
Srinivasu, T. (2018). Development of a New Validated Stability Indicating RP-HPLC Method for the Determination of Irbesartan and Hydrochlorothiazide. Asian Journal of Pharmaceutics (AJP), 12(01). https://doi.org/10.22377/ajp.v12i01.2081
Section
ORIGINAL ARTICLES